Chemical Compound

benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate

CAS Registry Number 641571-10-0
返回搜索 申请报价
benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate 结构式
Primary record

benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate

库存
4,871 克
纯度
98.2 %
CAS
641571-10-0

化合物标识与属性

CAS
641571-10-0
PubChem CID
644241
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
Canonical SMILES
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1

名称与同义词

  • Nilotinib
  • Tasigna
  • 641571-10-0
  • nilotinibum
  • Danziten
  • AMN107
  • Nilotinib free base
  • Nilotinib/
  • Nilotinib;
  • Nilotinib?
  • AMN 107
  • AMN-107
  • Nilotinib-d6
  • Nilotinib [USAN]
  • Nilotinib D6
  • Tasigna (Novartis)
  • Nilotinib (AMN-107)
  • Nilotinib(AMN-107)
  • Nilotinib (Standard)
  • 3gp0
  • NILOTINIB [INN]
  • RefChem:58968
  • Gallic Acid Cetyl Ester
  • NILOTINIB [MI]
  • C28H22F3N7O
  • MFCD09833716
  • Nilotinib (INN/USAN)
  • Nilotinib (USAN/INN)
  • AMN 107 Base
  • NILOTINIB [HSDB]
  • NILOTINIB [VANDF]
  • Nilotinib [USAN:INN:BAN]
  • D00STL
  • D06GGT
  • NILOTINIB [MART.]
  • Nilotinib, AMN107, Tasigna
  • AC1LD8U3
  • NILOTINIB [USP-RS]
  • NILOTINIB [WHO-DD]
  • SCHEMBL7901
  • CHEMBL255863
  • HHZIURLSWUIHRB-UHFFFAOYSA-N
  • DTXSID5042663
  • NILOTINIB [EMA EPAR]
  • cc-353
  • CHEBI:52172
  • HSDB 7842
  • MLS003915611
  • MLS006010160
  • Nilotinib & its intermediates
  • NSC-747599
  • Nilotinib - Bio-X trade mark
  • Nilotinib hydrochloride hydrate
  • Nilotinib hydrochloride monohydrate
  • GTPL5697
  • orb1308331
  • UNII-F41401512X
  • Tasigna, AMN-107, Nilotinib
  • DTXCID3022663
  • SCHEMBL29366964
  • SCHEMBL29580067
  • CTK8B3214
  • 641571-10-0 (free base)
  • L01XE08
  • QCR-112
  • SYN1057
  • NSC747599
  • BCPP000149
  • GLXC-90226
  • HMS3244A13
  • HMS3244A14
  • HMS3244B13
  • HMS3295A23
  • HMS3654M07
  • HMS3748E11
  • HMS5079M05
  • AOB87115
  • BCP01367
  • EX-A8380
  • KS-00000GT9
  • TAC35617
  • ZINC6716957
  • ABP000478
  • AC-647
  • ANW-41982
  • BDBM50237710
  • C28-H22-F3-N7-O
  • CID644241
  • EBC-11364
  • FC0027
  • HY-10159R
  • MSK159953
  • NSC800804
  • RS0102
  • s1033
  • F41401512X
  • 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide
  • AKOS005063561
  • ACN-038315
  • AN-5308
  • BCP9000989
  • CCG-264784
  • CS-0102
  • CS-O-01983
  • DB04868
  • FM10831
  • NSC 747599
  • NSC-800804
  • RTX-011143
  • SB17315
  • SDCCGSBI-0634418.P004
  • Nilotinib (BCR-ABL inhibitor 2nd gen)
  • NCGC00183285-01
  • NCGC00183285-03
  • NCGC00183285-04
  • NCGC00183285-09
  • NCGC00183285-15
  • 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide
  • AK-59889
  • AS-16214
  • BC224537
  • BN164654
  • BR-59889
  • EN002707
  • HY-10159
  • SC-19640
  • SMR002544680
  • SY024415
  • EC 700-544-5
  • 4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
  • AB0007991
  • ST2413627
  • TL8004531
  • A8232
  • AM20090651
  • FT-0654026
  • l-1-yl)-3-(trifluoromethyl)phenyl]benzamide
  • NS00000665
  • SW218083-2
  • V0705
  • EC-000.2344
  • J2.203.300J
  • A10644
  • D08953
  • N-8207
  • S-6060
  • 49312-EP2270008A1
  • 49312-EP2292617A1
  • 49312-EP2305667A2
  • 49312-EP2311840A1
  • 78680-EP2305667A2
  • AB01273978-01
  • AB01273978-02
  • AB01273978_03
  • EN300-7381984
  • 139316-EP2270008A1
  • 139316-EP2292617A1
  • 571N100
  • A834657
  • F079266
  • P111010
  • Q412327
  • SR-01000931150
  • 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
  • 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
  • I01-1225
  • SR-01000931150-2
  • BRD-K81528515-001-04-7
  • BRD-K81528515-001-13-8
  • 4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzamide
  • Z1741976994
  • B0084-074229
  • 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-{(4-(pyridin-3-yl)pyrimidin-2-yl)amino}benzamide
  • 4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
  • benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
  • MCL-1-specific antisense oligonucleotide + nilotinib (AMN107)
  • 1268356-17-7
  • 4-Methyl-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide
  • 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide
  • 4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
  • 4-Methyl-N-[3-(4-methyl-1-imidazolyl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]benzamide
  • 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide
  • 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide
  • 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzamide
  • Benzamide, 4-methyl-N-((3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-
  • N-(3-(3-(1H-Imidazolyl)propoxy)phenyl)-4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamide
  • NIL
  • Nilotinib,AMN107,Tasigna;4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
  • 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazo
  • 1215678-43-5
  • 1353151-22-0
  • 2,3,6-trideuterio-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-5-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-4-(trideuteriomethyl)benzamide
  • 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-N-[3-[4-(trideuteriomethyl)imidazol-1-yl]-5-(trifluoromethyl)phenyl]benzamide
  • 4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2
  • 4-Methyl-N-[3-(4-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzamide
  • 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
  • 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide
  • 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino] benzamide
  • 4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl]-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzamide
  • benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate
  • Benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-
  • Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- (9CI)
  • Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-(9CI)
  • Benzamide,4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
  • N-[3-(4-Methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[4-(3-pyridyl)pyrimidine-2-ylamino]benzamide
  • N-[3-(Trifluoromethyl)-5-(4-methyl-1H-imidazole-1-yl)phenyl]-4-methyl-3-[4-(3-pyridyl)-2-pyrimidinylamino]benzamide
  • n-[3-[3-(1h-imidazolyl)propoxy]phenyl]-4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide